ABVE vs XRAY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

ABVE

42.6
AI Score
VS
XRAY Wins

XRAY

44.3
AI Score

Investment Advisor Scores

ABVE

43score
Recommendation
HOLD

XRAY

44score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ABVE XRAY Winner
Forward P/E 0 6.3291 Tie
PEG Ratio 0 0.633 Tie
Revenue Growth -45.0% -4.1% XRAY
Earnings Growth 0.0% 15.2% XRAY
Tradestie Score 42.6/100 44.3/100 XRAY
Profit Margin -23.4% -15.0% XRAY
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

ABVE 1M: -79.2% · 3M: -91.4% XRAY 1M: -18.8% · 3M: -25.0%

Current Technical Phase

ABVE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -29.1%), weak momentum, RSI 28

RSI (14): 28.0 · Price: $0.11

XRAY

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.5%), weak momentum, RSI 28

RSI (14): 28.4 · Price: $8.74

Fundamentals Snapshot

Metric ABVE XRAY
Market Cap — —
Forward P/E 0.0 5.8
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.5% 0.0%
Gross Margin 0.0% 0.5%
Operating Margin -0.2% 0.1%
EPS -1.75 -2.69
Dividend Yield — 0.04%

Frequently Asked Questions

Based on our detailed analysis, XRAY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.